Abstract

Background: Nocturia is night waking for voiding, is a lower urinary tract problem of anxious symptom. nocturnal polyuria, diminished capacity of the bladder either nocturnal and/or global capacity, and sleep impairment are main pathophysiologic subtypes. fluid restriction mainly awhile before the bed time, anticholinergic therapy, diuretics and hormone replacement therapy are main preventive strategies. Aim of Study: To determine the oral desmopressin efficacy and safety of in nocturia of women as a treatment. Patients and methods: - Sixty-four women with18-80 years� age with nocturia (nocturia index score >1, more than two voids per night) were invited to attend our study. randomly assigned patients into: 32 women received different desmopressin doses (0.2, 0.4, or 0.6 mg) during dose-titration period(three-weeks), and the other 32 ones received single- blind placebo treatment for 6 or 8 weeks according to their response. Results: In single-blind phase, for desmopressin, 30 (93.75 %) patients with fifty percent or more nocturnal voids reduction against the baseline levels in comparison to only 3 (9.7%)placebo-receiving patients where (P < 0.001). The mean nocturnal voids No., sleep period till 1st nocturnal void, nocturnal diuresis, and allover day volumes changed signscantly preferring desmopressin. (P

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.